COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 74 filers reported holding COMPASS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,415,500 | -61.4% | 1,226,142 | -37.7% | 1.01% | -32.5% |
| Q2 2023 | $6,262,361 | -12.0% | 1,969,296 | -9.5% | 1.50% | -23.9% |
| Q1 2023 | $7,118,927 | -36.5% | 2,177,042 | -2.4% | 1.96% | -59.3% |
| Q4 2022 | $11,219,000 | +300.0% | 2,230,441 | +81.3% | 4.83% | +364.3% |
| Q3 2022 | $2,805,000 | -14.0% | 1,230,441 | 0.0% | 1.04% | -12.4% |
| Q2 2022 | $3,261,000 | +87.4% | 1,230,441 | -3.1% | 1.19% | +135.5% |
| Q1 2022 | $1,740,000 | -72.6% | 1,270,211 | -36.5% | 0.50% | -67.8% |
| Q4 2021 | $6,340,000 | – | 2,000,000 | – | 1.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,500,000 | $11,165,000 | 7.28% |
| Foresite Capital Management V, LLC | 4,400,000 | $13,948,000 | 3.43% |
| CHI Advisors LLC | 3,023,692 | $9,585,000 | 3.18% |
| Foresite Capital Opportunity Management V, LLC | 1,100,000 | $3,487,000 | 2.34% |
| Monashee Investment Management LLC | 2,000,000 | $6,340,000 | 1.57% |
| Orbimed Advisors | 21,642,975 | $68,608,000 | 0.88% |
| Rock Springs Capital Management LP | 5,328,088 | $16,890,000 | 0.39% |
| Vivo Capital, LLC | 2,000,000 | $6,340,000 | 0.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 700,000 | $2,219,000 | 0.24% |
| DAFNA Capital Management LLC | 196,091 | $622,000 | 0.16% |